PROCESSED AT :
Thyrocare
NAME : XXXXXXXXXXXXXXXXXX
REF. BY : XXXXXXXXXXXXXXXXXX
TEST ASKED : QUANTIFERON -TB GOLD PLUS
PATIENTID : XXXXXXXXXXXXXXXXX
TEST NAME Results UNITS
QUANTIFERON - TB GOLD PLUS
TB1 ANTIGEN TUBE MINUS NIL TUBE 2.24 IU/mL
TB2 ANTIGEN TUBE MINUS NIL TUBE 2.11 IU/mL
MITOGEN TUBE MINUS NIL TUBE 1.4 IU/mL
NIL TUBE 1.16 IU/mL
FINAL RESULT POSITIVE
INTERPRETATION
Sample Collected on (SCT) : Sample collection time
Sample Received on (SRT) : Sample receiving time at Lab
Report Released on (RRT) : Report release time
Sample Type : BLOOD
Labcode : Doctor 1 Sign Doctor 2 Sign
Barcode :
Page : 1 of 3
NOTE
1 A positive result indicates the IFN-Gamma response to M. tuberculosis antigens in patient’s sample
suggestive of probable exposure to M. tuberculosis.
2 This assay is an indirect test for Mycobacterium tuberculosis infection including diseases and is
intended for use in conjunction with clinical findings and other diagnostic tests.
3 False-positive results may occur in patient’s with prior infection with M marium, M szulgai, or M
kansasii.
4 A Negative result indicates absence of IFN-Gamma Response to M. Tuberculosis antigen in
patients sample but does not preclude the possibility of [Link] infection or tuberculosis
disease.
5 False Negative results can be due to stage of infection (e.g. sample taken prior to the
development of cellular immune response), Co-morbid conditions that affect immune functions .
6 Low lymphocyte counts, reduced or no activation of immune response to TB antigens or other
immunological variables. CDC recommends repeat test after 8-10 weeks in case of high suspicion of
tuberculosis.
7 Indeterminate results can be seen in HIV positive individuals with CD4 Count ≤ 200 cells/mL, In
Children < 4 years of age, recent illness, presence of heterophile antibodies in the patient’s
sample, Compromised immune state and recent vaccinations.
8 The magnitude of the measured IFN-Gamma level cannot be correlated to the stage or degree of
infection, level of immune responsiveness, likelihood of progression of active disease or to
omonitor TB therapy.
COMMENTS
This assay is an indirect test for Mycobacterium tuberculosis infection including disease and is intended
for use in conjunction with risk assessment, radiography and other medical and diagonostic evaluations.
~~ End of report ~~
Sample Collected on (SCT) : Sample collection time
Sample Received on (SRT) : Sample receiving time at Lab
Report Released on (RRT) : Report release time
Sample Type : BLOOD
Labcode : Doctor 1 Sign Doctor 2 Sign
Barcode :
Page : 1 of 3
CUSTOMER DETAILS
As declared in our data base
Name: XXXXXXXXXXXXX Age: XX Sex: XX
Barcodes/Sample_Type :
Labcode :
Ref By : XXXXXXXXXXXXXXXXXXXXXXXXXX
Sample_Type/Tests : LITHIUM HEPARIN:ZZZZ
LITHIUM HEPARIN:QUANTIFERON -TB GOLD PLUS
Sample Collected At :
Sample Collected on (SCT) : Sample collection time
Report Released on (RRT) : Report release time
Amount Collected : -
Thyrocare,D-37/1,MIDC,Turbhe,Navi Mumbai - 400703. | Phone:022 - 6712 3400 |[Link] | info@[Link]
Page : 2 of 3
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- [Link]
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v [Link] - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@[Link] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 3 of 3
